ST Pharm Reports Operating Loss of 9.2 Billion KRW in Q1... Loss Widens
[Asia Economy Reporter Oh Ju-yeon] ST Pharm announced on the 29th that its consolidated operating loss for the first quarter of this year widened to 9.2 billion KRW compared to the same period last year. Sales increased by 28.5% to 20.2 billion KRW, and the net loss for the period decreased to 4.6 billion KRW compared to the same period last year.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
